In our latest 23 Questions, Victoria Maharaj tackles rapid-fire questions, from how our advanced FUEL™ platform can boost productivity through our innovative technologies, proven processes, and strategic optimizations to insights on Forge's unique Technical Sales team—and even her dream tennis matchup! Read the full blog here ➡️ https://hubs.li/Q02Z6zk90
Forge Biologics
Biotechnology Research
Columbus, Ohio 21,383 followers
A member of Ajinomoto Bio-Pharma Services
About us
Forge, a member of Ajinomoto Bio-Pharma Services, is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech/pharma companies, and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them most.
- Website
-
http://www.forgebiologics.com
External link for Forge Biologics
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Columbus, Ohio
- Type
- Privately Held
- Founded
- 2020
- Specialties
- AAV, Gene Therapy, Biotech, and cGMP
Locations
-
Primary
Get directions
Columbus, Ohio, US
Employees at Forge Biologics
Updates
-
"Gene therapy manufacturing is complex, resource-intensive, and time-sensitive—every day matters for developers and their patients.” We are proud Affinia Therapeutics has chosen Forge as their manufacturing partner to help address these challenges and advance their program focused on cardiovascular diseases. John Maslowski shared more about this collaboration with BioProcess International editor Joshua Abbott. Read the full article: https://hubs.li/Q02YQ6YP0
-
Back from Boston! Last week, the Forge team joined the Mass General Brigham Gene and Cell Therapy Research Symposium. Our AAV experts, Laura Carfagna and Rachael Hardison, Ph.D., were there connecting with innovators and gaining the latest insights in gene therapy research and development. Missed us at the event? Let’s connect! https://hubs.li/Q02YLTLL0
-
-
From cold chain logistics to classic TV favorites, this month's Genes of Interest spotlights the unique specialties of Keldon Marth, Senior Logistics Manager of Cold Chain at Forge. Leading a vital team at Forge, he ensures everything from QC materials to final drug products arrives securely and on time. Discover how Forge's core values of HOPE inspire him, his fascinating family aviation history, and career advice for breaking into gene therapy. Dive into Keldon's story here ➡️ https://hubs.li/Q02YqcYm0
-
-
Our Head of HR, Liza Lewis, SHRM-CP, has joined the Ohio Life Sciences Foundation Board! We’re thrilled to have her in this role, strengthening Forge's commitment to building a thriving biotech ecosystem in Ohio. With Liza’s strategic leadership contributions to OLS, we’re forging even stronger regional partnerships to ensure our life sciences organizations have access to the workforce needed to succeed. Read the full press release and see the complete list of board members here: https://hubs.li/Q02YhQbj0
-
-
It’s #WorldQualityDay, and we’re thrilled to spotlight our exceptional Quality team who is committed to ensuring the delivery of safe, transformative gene therapies with the highest standards of quality, integrity, and compliance. Forge’s collective commitment to quality highlights its vital role within our organization, and is what allows us to continue to deliver on our mission of enabling access to life-changing therapies for our clients and the patients they serve around the world. Thank you, Forge #QualityChampions!
-
-
We are pleased to announce our AAV manufacturing partnership with Affinia Therapeutics to help advance their pipeline of next-generation gene therapies to the clinic. Our partnership includes tech transfer and cGMP manufacturing services for Affinia’s investigational gene therapy for dilated cardiomyopathy. Read the full press release here: https://hubs.li/Q02Y0L6X0
-
🎉 We're thrilled to announce that, for the second year in a row, Forge has been named one of BioSpace's Best Places to Work! At Forge, our team is guided by the core values of HOPE and united by our mission of bringing life-changing discoveries from concept to reality. A heartfelt thank you to our incredible team for their unwavering dedication and hard work. Read the report to see the 50 global companies earning this distinction with us ➡️ https://bit.ly/3YMymK7
-
Today and every day, Forge honors the courage, commitment, and sacrifices of our veterans and their families. We’re deeply grateful to the veterans at Forge, within our community, and across the nation who have selflessly protected our freedoms. This Veterans Day, Forge is proud to observe this holiday in their honor. To all who have served and continue to serve, thank you.
-
-
On this #NationalSTEMDay, we celebrate the power of science, technology, engineering, and math in shaping breakthroughs in genetic medicine. At Forge, our team is built on careers in #STEM, and we’re dedicated to broadening pathways to jobs in biotech through K-12 education, college and university partnerships, and community engagement. We believe that expanding knowledge and opportunity helps build a more inclusive and brighter future. #NationalSTEMDay #ForgeWithUs